MADIT-II and its implications

European Heart Journal

Volumn 24, Issue 1, 2003, Pages 16-18

  Moss, A J ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

CONFERENCE PAPER; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DEFIBRILLATION; HEART ARRHYTHMIA; HEART DEATH; HEART EJECTION FRACTION; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HIGH RISK PATIENT; PATIENT CARE; PRIORITY JOURNAL; PROPHYLAXIS; SECONDARY PREVENTION; SURVIVAL;

CLINICAL TRIALS; CORONARY DISEASE; DEFIBRILLATORS, IMPLANTABLE; HUMANS; MULTICENTER STUDIES; MYOCARDIAL ISCHEMIA;

EID: 0037236484     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-668X(02)00627-9     Document Type: Conference Paper

References (14)

1. Center for Disease Control. State specific mortality from sudden cardiac death-United States, 1999. MMWR 2002; 51:123-6.
2. Echt DS, Liebson PR, Mitchell LB et al. Mortality and morbidity in patients receiving encainide, flecaínide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991;324:781-8.
3. Moss AJ, Hall WJ, Cannom DS et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996;335:1933-40.
4. Moss AJ, Fadl Y, Zareba W et al. Survival benefit with an implanted defibrillator in relation to mortality risk in chronic coronary heart disease. Am J Cardiol 2001; 88:516-20.
5. Singh SN, Fletcher RD, Fisher SG et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. N Engl J Med 1995; 333:77-82.
6. Julian DG, Camm AJ, Frangin G et al. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators. Lancet 1997;349:667-74.
7. Cairns JA, Connolly SJ, Roberts R et al. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricutar premature depotarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. Lancet 1997;349:675-82.
8. Moss AJ, Cannom D, Daubert JP et al. Multicenter automatic defibrillator implantation trial II (MADIT II): Design and clinical protocol. Ann Noninvasive Electrocard 1999; 4:83-91.
9. Moss AJ, Zareba W, Hall WJ et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346:877-83.
10. www.fda.gov. FDA approves expanded indication for Guidant implantable cardioverter defibrillator for heart attack survivors, July 18, 2002.
11. Beta-blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction. JAMA 1982;247:1707-21.
12. CASS Principal Investigators. Coronary Artery Surgery Study (CASS): a randomized trial of coronary artery bypass surgery: survival data. Circulation 1983;68:951-60.
13. Pfeffer MA, Braunwald E, Moye LA et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 1992;327:669-77.
14. Mushlin AI, Hatt WJ, Zwanziger J et al. The cost-effectiveness of automatic implantable cardiac defibrillators: results from MADIT. Multicenter Automatic Defibrillator Implantation Trial. Circulation 1998;97: 2129-35.